These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1598048)

  • 1. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia].
    Ranklev-Twetman E; Isander G; Fletcher R
    Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hyperthermia in myotonia congenita.
    Heiman-Patterson T; Martino C; Rosenberg H; Fletcher J; Tahmoush A
    Neurology; 1988 May; 38(5):810-2. PubMed ID: 3362383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant hyperthermia under general anaesthesia. Abnormal histochemical and electron-microscopic muscle findings in combination with pathological serum-CPK-values evidencing the existence of primary myopathy (author's transl)].
    Bernhardt D; Schiller H
    Anaesthesist; 1973 Aug; 22(8):367-72. PubMed ID: 4270680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia or myotonia congenita].
    Amores Lloret A; Martínez Hernández A
    Rev Esp Anestesiol Reanim; 1988; 35(6):346. PubMed ID: 3238135
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant hyperthermia and myotonia congenita (Thomsen's disease).
    Haberer JP; Fabre F; Rose E
    Anaesthesia; 1989 Feb; 44(2):166. PubMed ID: 2929948
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure to induce malignant hyperthermia in myotonic goats.
    Newberg LA; Lambert EH; Gronert GA
    Br J Anaesth; 1983 Jan; 55(1):57-60. PubMed ID: 6821623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central core disease. Clinical features in 13 patients.
    Shuaib A; Paasuke RT; Brownell KW
    Medicine (Baltimore); 1987 Sep; 66(5):389-96. PubMed ID: 3626847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Malignant hyperpyrexia.
    Furniss P
    Br Med J; 1975 Jan; 1(5949):92. PubMed ID: 1109671
    [No Abstract]   [Full Text] [Related]  

  • 9. [Malignant hyperthermia--genetic diagnosis is not yet possible].
    Islander G; Twetman ER
    Lakartidningen; 1997 May; 94(21):1972. PubMed ID: 9198685
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Myopathies and malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 Aug; 3(5929):520. PubMed ID: 4414306
    [No Abstract]   [Full Text] [Related]  

  • 11. Linkage studies of Myotonia congenita and Paramyotonia congenita.
    Bender K; Senff H; Steiert A; Lagodny H; Wienker TF; Koch M
    Clin Genet; 1989 Aug; 36(2):92-9. PubMed ID: 2766573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility.
    Zaharieva IT; Sarkozy A; Munot P; Manzur A; O'Grady G; Rendu J; Malfatti E; Amthor H; Servais L; Urtizberea JA; Neto OA; Zanoteli E; Donkervoort S; Taylor J; Dixon J; Poke G; Foley AR; Holmes C; Williams G; Holder M; Yum S; Medne L; Quijano-Roy S; Romero NB; Fauré J; Feng L; Bastaki L; Davis MR; Phadke R; Sewry CA; Bönnemann CG; Jungbluth H; Bachmann C; Treves S; Muntoni F
    Hum Mutat; 2018 Dec; 39(12):1980-1994. PubMed ID: 30168660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic testing to diagnose malignant hyperthermia susceptibility.
    Girard T; Litman RS
    J Clin Anesth; 2008 May; 20(3):161-3. PubMed ID: 18502356
    [No Abstract]   [Full Text] [Related]  

  • 14. [When all roads lead to Africa…].
    Urtizberea JA; Alrohaif H; Gouda SA; Bastaki L
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():15-17. PubMed ID: 31859625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current aspects of anesthesia in neuromuscular diseases].
    Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jul; 38(7):495-9. PubMed ID: 12822125
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant hyperthermia: advances in clinical management and diagnosis.
    Hopkins PM
    Br J Anaesth; 2000 Jul; 85(1):118-28. PubMed ID: 10928000
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant malignant hyperthermia.
    Bross T; Steinmann D
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):164-5. PubMed ID: 18173438
    [No Abstract]   [Full Text] [Related]  

  • 18. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of the diagnosis of malignant hyperthermia].
    Rüffert H; Olthoff D; Deutrich C; Froster UG
    Anaesthesist; 2002 Nov; 51(11):904-13. PubMed ID: 12434264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiomyopathy and hereditary neuromuscular disorders].
    Rahlf G; Fischer G; Bachmann M
    Verh Dtsch Ges Pathol; 1982; 66():400-10. PubMed ID: 7184266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.